The Anatolian Journal of Cardiology

[Anatol J Cardiol]
Anatol J Cardiol. 2018; 19(2): 117-122 | DOI: 10.14744/AnatolJCardiol.2017.8019  

Relation between high serum hepcidin-25 level and subclinical atherosclerosis and cardiovascular mortality in hemodialysis patients

Özlem Yayar1, Barış Eser2, Harun Kılıç3
1Department of Nephrology, Çanakkale State Hospital; Çanakkale-Turkey
2Department of Nephrology, Hitit University, Erol Olcok Training and Research Hospital; Çorum-Turkey
3Department of Cardiology, Faculty of Medicine, Sakarya University; Sakarya-Turkey

Objective: In hemodialysis (HD) patients, cardiovascular disease (CVD) is the major cause of mortality and morbidity. In atherosclerotic diseases, iron gets accumulated in the arterial wall. Hepcidin is an important hormone in iron metabolism. Furthermore, hepcidin is associated with atherosclerotic disease. Therefore, this study aims to investigate the relation of serum hepcidin-25 (SH-25) and sub-clinic atherosclerosis measured by carotid intima-media thickness (CIMT) and mortality in HD patients.
Methods: We enrolled 82 HD patients in a cross-control study. We measured SH-25 using ELISA kit and CIMT using high-resolution real-time ultrasonography. After 4 years of first assessment, we investigated the relation between all-cause and cardiovascular mortality and SH-25 and CIMT.
Results: Two patients were excluded because of renal transplantation. The survivors were younger (53.7±15.1 vs. 65.2±15.5; p<0.05) and CIMT was lower (0.83±0.2 vs. 0.95±0.2; p<0.05); however, there was no significant difference in SH-25 levels between the groups (29.1±13 vs. 32.4±22.4;p=0.767). The patients who died of CVD were significantly older (63.7±16.1 vs. 53.7±15.1; p<0.05) and had significantly higher CIMT (0.94±0.2 vs. 83±0.2; p<0.05). The SH-25 levels were statistically significantly higher in patients who died of CVD (40.3±25 vs. 29.1±13; p<0.05). Linear regression
analysis showed a positive correlation between CIMT and SH-25 in the study population and in those who died from CVD (r=0.41; p<0.05 and r=0.606; p<0.05, respectively).
Conclusion: This study suggests that hepcidin is effective in cardiovascular mortality and pathophysiology of subclinical atherosclerosis in HD patients.

Keywords: cardiovascular mortality, carotid intima-media thickness, hemodialysis, hepcidin


Özlem Yayar, Barış Eser, Harun Kılıç. Relation between high serum hepcidin-25 level and subclinical atherosclerosis and cardiovascular mortality in hemodialysis patients. Anatol J Cardiol. 2018; 19(2): 117-122

Sorumlu Yazar: Barış Eser, Türkiye


ARA�LAR
Tam Metin PDF
Yazdır
Al�nt�y� �ndir
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
E-Postala
Payla�
Yazara e-posta g�nder

Benzer makaleler
PubMed
Google Scholar